Stifel Financial Corp Eliem Therapeutics, Inc. Transaction History

Stifel Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.48 - $3.15 $620 - $787	-250 Reduced 1.68%	14,650 $38,000
Q2 2023 Aug 14, 2023	BUY	$2.34 - $3.72 $88 - $141	38 Added 0.26%	14,900 $41,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.69 $3,224 - $4,797	-1,300 Reduced 8.04%	14,862 $54,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $3.97 $9,063 - $13,228	3,332 Added 25.97%	16,162 $52,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $8.4 $7,404 - $22,453	2,673 Added 26.32%	12,830 $39,000
Q1 2022 May 13, 2022	BUY	$8.01 - $13.15 $81,357 - $133,564	10,157 New	10,157 $85,000

53.1M

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.